[1] |
Mall V, Heinen F, Linder M, et al. Treatment of cerebral palsy with botulinum toxin A: functional benefit and reduction of disability. Three case reports[J]. Pediatr Rehabil, 1997, 1(4): 235-237. DOI: 10.3109/17518429709167364.
|
[2] |
Picelli A, Vallies G, Chemello E, et al. Is spasticity always the same? An observational study comparing the features of spastic equinus foot in patients with chronic stroke and multiple sclerosis[J]. J Neurol Sci, 2017, 380(Sep 15): 132-136. DOI: 10.1016/j.jns.2017.07.026.
|
[3] |
张迪, 史凤之, 吴健, 等. 大圆肌挛缩症一例报告[J]. 中华骨科杂志, 2012, 32(4): 385. DOI: 10.3760/cma.j.issn.0253-2352.2012.04.018.
|
[4] |
Coskun Benlidayi I, Basaran S. Hemiplegic shoulder pain: a common clinical consequence of stroke[J]. Practical Neurology, 2014, 14(2): 88-91. DOI: 10.1136/practneurol-2013-000606.
|
[5] |
Decq P, Filipetti P, Feve A, et al. Peripheral selective neurotomy of the brachial plexus collateral branches for treatment of the spastic shoulder: anatomical study and clinical results in five patients[J]. J Neurosurg, 1997, 86(4): 648-653. DOI: 10.3171/jns.1997.86.4.0648.
|
[6] |
Sindou MP, Simon F, Mertens P, et al. Selective peripheral neurotomy (SPN) for spasticity in childhood[J]. Child's Nervous System, 2007, 23(9): 957-970. DOI: 10.1007/s00381-007-0399-1.
|
[7] |
García-Sánchez SF, Gómez-Galindo MT, Guzmán-Pantoja JE. Botulinum toxin A and physical therapy in gait in cerebral palsy[J]. Revista Medica Del Instituto Mexicano Del Seguro Social, 2017, 55(1): 18-24. PMID: 28092243.
|
[8] |
Michaud LJ, Louden EJ, Lippert WC, et al. Use of Botulinum toxin type A in the management of neonatal brachial plexus palsy[J]. PM&R, 2014, 6(12): 1107-1119. DOI: 10.1016/j.pmrj.2014.05.002.
|
[9] |
Ertzgaard P, Anhammer M, Forsmark A. Regional disparities in botulinum toxin A(BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap[J]. Acta Neurol Scand, 2017, 135(3): 366-372. DOI: 10.1111/ane.12610.
|
[10] |
Tang S, Zhang MX, Yang S. Localization of center of intramuscular nerve dense regions in adult anterior brachial muscles a guide for botulinum toxin A injection to treat muscle spasticity[J]. Am J Transl Res, 2018, 10(4): 1220-1228. PMID: 29736215.
|
[11] |
Wang J, Wang Q, Zhu D, et al. Localization of the center of the intramuscular nerve dense region of the medial femoral muscles and the significance for blocking spasticity[J]. Ann Anat, 2020, 231: 151529. DOI: 10.1016/j.aanat.2020.151529.
|
[12] |
Friedman A, Diamond M, Johnston MV, et al. Effects of botulinum toxin A on upper limb spasticity in children with cerebral palsy[J]. Am J Phys Med Rehabil, 2000, 79(1): 53-59. DOI: 10.1097/00002060-200001000-00012.
|
[13] |
Jihye P, Myung C. Botulinum toxin for central neuropathic pain[J]. Toxins, 2018, 10(6): 224. DOI: 10.3390/toxins10060224.
|
[14] |
Amirali A, Mu L, Gracies JM, et al. Anatomical localization of motor endplate bands in the human biceps brachii[J]. J Clin Neuromuscul Dis, 2007, 9(2): 306-312. DOI: 10.1097/CND.0b013e31815c13a7.
|
[15] |
王猛, 王国亚, 杨胜波. 大圆肌的神经入肌点定位及其临床意义[J]. 中国临床解剖学杂志, 2017, 35(5): 486-489. DOI:?10.13418/j.issn.1001-165x.2017.05.002.
|
[16] |
中国康复医学会. 肉毒毒素治疗成人肢体痉挛状态中国指南(2015)[J]. 中国康复医学杂志, 2015, 30(1):81-110. DOI: 10.3969/j.issn. 1001-1242.2015.01.023.
|
[17] |
Kasapoğlu-Aksoy M, Aykurt-Karlıbel İ, Altan L. Comparison of the efficacy of intramuscular botulinum toxin type-A injection into the pectoralis major and the teres major muscles and suprascapular nerve block for hemiplegic shoulder pain: a prospective, double-blind, randomized, controlled trial[J]. Neurol Sci, 2020,41(8): 2225-2230. DOI: 10.1007/s10072-020-04334-4.
|
[18] |
Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related dffusion and muscle fiber response after therapeutic botulinum A toxin injections[J]. Mov Disord, 1994, 9(1): 31-39. DOI:?10.1002/mds.870090106.
|
[19] |
Ghasemi M, Salari M, Khorvash F, Shaygannejad V. A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity[J]. Int J Prev Med, 2013, 4 (Suppl 2): S147-158. PMID:23776717.
|